Skip to main content

RHUMBLINE ADVISERS

Position in JBIO — Jade Biosciences, Inc.

CIK 1115418 BOSTON, MA

Position in JBIO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$908,975
+$339,234 QoQ
Shares Held
40,908
+0.9% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 153 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 23% Shared 0% None 77%

Common Shares in JBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. JBIO ranks #143 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in JBIO

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $908,975 40,908
2026-03-31 $569,741 40,551
2025-12-31 $772,317 50,053
2025-09-30 $369,225 42,784
2025-06-30 $445,254 44,570
2025-03-31 AVTE 22,750
2024-12-31 AVTE 13,596
2024-09-30 AVTE 13,266
2024-06-30 AVTE 15,084
2024-03-31 AVTE 14,622
2023-12-31 AVTE 14,157
2023-09-30 AVTE 13,993
2023-06-30 AVTE 12,986
2023-03-31 AVTE 14,798
2022-12-31 AVTE 14,232
2022-09-30 AVTE 14,142
2022-06-30 AVTE 13,193